Published in Annu Rev Biochem on January 01, 2000
Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev (2009) 5.64
Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol (2011) 4.67
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest (2006) 4.50
Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res (2009) 2.71
Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev (2011) 2.48
Control of oxygenation in lipoxygenase and cyclooxygenase catalysis. Chem Biol (2007) 2.29
Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci U S A (2003) 2.23
Cyclooxygenases: structural and functional insights. J Lipid Res (2008) 2.14
Why there are two cyclooxygenase isozymes. J Clin Invest (2001) 2.13
Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res (Phila) (2009) 2.06
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2004) 2.05
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest (2006) 2.03
A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am J Pathol (2009) 1.99
The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J Exp Med (2003) 1.87
Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol Cell Biol (2008) 1.75
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prev Res (Phila) (2008) 1.71
Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies. FASEB J (2006) 1.71
Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem Rev (2011) 1.67
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat Med (2015) 1.66
Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers. J Biol Chem (2009) 1.60
Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest (2006) 1.58
Heme enzyme structure and function. Chem Rev (2014) 1.58
Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation. J Lipid Res (2009) 1.58
Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways. Chem Rev (2011) 1.56
Prostaglandin signalling regulates ciliogenesis by modulating intraflagellar transport. Nat Cell Biol (2014) 1.55
The cyclooxygenases. Genome Biol (2004) 1.55
The G12 family of G proteins as a reporter of thromboxane A2 receptor activity. Mol Pharmacol (2006) 1.53
Overexpressed transient receptor potential vanilloid 3 ion channels in skin keratinocytes modulate pain sensitivity via prostaglandin E2. J Neurosci (2008) 1.53
Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res (2007) 1.52
Partnering between monomers of cyclooxygenase-2 homodimers. Proc Natl Acad Sci U S A (2006) 1.49
Concern Novel allelic variants in the canine cyclooxgenase-2 (Cox-2) promoter are associated with renal dysplasia in dogs. PLoS One (2011) 1.48
Overexpression of lecithin:retinol acyltransferase in the epithelial basal layer makes mice more sensitive to oral cavity carcinogenesis induced by a carcinogen. Cancer Biol Ther (2009) 1.47
Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am J Pathol (2004) 1.47
Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom (2006) 1.45
Leukocyte lipid bodies - Biogenesis and functions in inflammation. Biochim Biophys Acta (2009) 1.44
Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment. Crit Rev Oncol Hematol (2008) 1.42
IgE, COX-2, and IL-4 are expressed by DEHP through p38 MAPK and suppressed by plant glycoprotein (75 kDa) in ICR mice. Inflammation (2011) 1.42
Biological responses of three-dimensional cultured fibroblasts by sustained compressive loading include apoptosis and survival activity. PLoS One (2014) 1.37
The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. J Biol Chem (2008) 1.37
Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine (2010) 1.37
Eicosanoid storm in infection and inflammation. Nat Rev Immunol (2015) 1.35
Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog (2010) 1.35
Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem (2010) 1.33
Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer. J Biol Chem (2011) 1.31
Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation. Genes Dev (2006) 1.28
A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol (2004) 1.28
Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J Gastroenterol (2005) 1.26
The Role of PPARs in Cancer. PPAR Res (2008) 1.26
Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J Biol Chem (2008) 1.26
Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence. Infect Immun (2005) 1.23
The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword. Prog Neurobiol (2010) 1.23
Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells. J Biol Chem (2010) 1.22
Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia. Proc Natl Acad Sci U S A (2011) 1.21
Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res (2002) 1.20
Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. Am J Pathol (2009) 1.20
COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems. Am J Pathol (2010) 1.20
Mechanisms of deoxynivalenol-induced gene expression and apoptosis. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2008) 1.19
COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice. J Clin Invest (2009) 1.18
Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. J Virol (2006) 1.18
Prostaglandin H synthase: resolved and unresolved mechanistic issues. Arch Biochem Biophys (2009) 1.18
Redox signaling in cardiovascular health and disease. Free Radic Biol Med (2013) 1.16
The structural basis of endocannabinoid oxygenation by cyclooxygenase-2. J Biol Chem (2011) 1.16
Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway. Circulation (2007) 1.15
Inhibition of cyclooxygenases by dipyrone. Br J Pharmacol (2007) 1.14
A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin. Proc Natl Acad Sci U S A (2001) 1.13
Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res (2009) 1.13
Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity. J Biol Chem (2011) 1.13
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. Br J Cancer (2006) 1.13
Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus. J Virol (2006) 1.13
Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell Immunol (2009) 1.12
Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis. Proc Natl Acad Sci U S A (2009) 1.12
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. Proc Natl Acad Sci U S A (2003) 1.11
Lipidomics analysis of essential fatty acids in macrophages. Prostaglandins Leukot Essent Fatty Acids (2008) 1.10
Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice. J Hepatol (2010) 1.10
A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells. J Neuroinflammation (2009) 1.10
Convergence of nitric oxide and lipid signaling: anti-inflammatory nitro-fatty acids. Free Radic Biol Med (2008) 1.09
Molecular mechanisms of mouse skin tumor promotion. Cancers (Basel) (2010) 1.09
Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells. J Immunol (2006) 1.08
Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4. Cancer Res (2007) 1.08
Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells. PLoS One (2011) 1.08
COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. Bone (2008) 1.07
Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch (2004) 1.07
Identification of PpoA from Aspergillus nidulans as a fusion protein of a fatty acid heme dioxygenase/peroxidase and a cytochrome P450. J Biol Chem (2009) 1.06
Specificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype. J Leukoc Biol (2011) 1.06
Sulindac suppresses beta-catenin expression in human cancer cells. Eur J Pharmacol (2008) 1.06
Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies. Mol Cancer Res (2008) 1.05
Multiple roles of dihomo-γ-linolenic acid against proliferation diseases. Lipids Health Dis (2012) 1.04
Distinct protein kinase A anchoring proteins direct prostaglandin E2 modulation of Toll-like receptor signaling in alveolar macrophages. J Biol Chem (2011) 1.04
An unbiased systems genetics approach to mapping genetic loci modulating susceptibility to severe streptococcal sepsis. PLoS Pathog (2008) 1.04
A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia. Pharmacogenomics J (2008) 1.04
Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur J Nutr (2009) 1.04
p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes. Elife (2014) 1.03
The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression. Oncogene (2010) 1.03
Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response. Mol Pharmacol (2007) 1.03
Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther (2013) 1.03
Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells. Mol Cancer (2010) 1.02
COX-2 and cancer: a new approach to an old problem. Br J Pharmacol (2001) 1.02
EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells. Am J Respir Cell Mol Biol (2007) 1.02
The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development. Carcinogenesis (2009) 1.02
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature (1994) 5.94
Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem (1996) 4.63
Biologically active carbazole alkaloids from Murraya koenigii. J Agric Food Chem (1999) 4.43
Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem (1993) 4.05
The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol (1995) 2.56
Specimen preparation for electron microscopy using low temperature embedding resins. J Microsc (1982) 2.33
Three-dimensional crystals of an integral membrane protein: an initial x-ray analysis. J Cell Biol (1980) 2.31
X-ray diffraction analysis of matrix porin, an integral membrane protein from Escherichia coli outer membranes. J Mol Biol (1983) 2.29
Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J Nat Prod (1999) 1.94
Oxygen activation and reduction in respiration: involvement of redox-active tyrosine 244. Science (2000) 1.89
The structure of OmpF porin in a tetragonal crystal form. Structure (1995) 1.87
Secondary structure of a channel-forming protein: porin from E. coli outer membranes. EMBO J (1985) 1.87
The productive conformation of arachidonic acid bound to prostaglandin synthase. Science (2000) 1.85
Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem (1995) 1.82
Prostaglandin and thromboxane biosynthesis. Pharmacol Ther (1991) 1.81
Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem (1994) 1.78
Structure of the UDP-glucosyltransferase GtfB that modifies the heptapeptide aglycone in the biosynthesis of vancomycin group antibiotics. Structure (2001) 1.69
Isolation and crystallization of bacterial porin. Methods Enzymol (1986) 1.69
Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest (1997) 1.67
Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol (1997) 1.64
Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid. J Biol Chem (1995) 1.45
Prostaglandin endoperoxide H synthase-1: the functions of cyclooxygenase active site residues in the binding, positioning, and oxygenation of arachidonic acid. J Biol Chem (2000) 1.43
Similarities in active center geometries of zinc-containing enzymes, proteases and dehydrogenases. J Mol Biol (1978) 1.40
Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site. Biochemistry (1996) 1.37
Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine (2000) 1.35
The structure of mammalian hexokinase-1. Nat Struct Biol (1998) 1.31
Interleukin-1 alpha induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts. J Biol Chem (1992) 1.28
Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol (1995) 1.27
Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis. J Biol Chem (1990) 1.27
Structure of eicosapentaenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1. J Biol Chem (2001) 1.26
Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem Biophys Res Commun (1992) 1.25
Detergent structure in tetragonal crystals of OmpF porin. Structure (1995) 1.25
N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J Biol Chem (1993) 1.21
Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem (1994) 1.19
The Chou-Fasman secondary structure prediction method with an extended data base. FEBS Lett (1978) 1.18
Recombinant Arabidopsis SQD1 converts udp-glucose and sulfite to the sulfolipid head group precursor UDP-sulfoquinovose in vitro. J Biol Chem (2000) 1.18
The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors. J Biol Chem (1999) 1.15
Convergence of active center geometries. Biochemistry (1977) 1.14
Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann N Y Acad Sci (1994) 1.13
The orientation of beta-sheets in porin. A polarized Fourier transform infrared spectroscopic investigation. Biophys J (1988) 1.10
Structural investigations of outer membrane proteins from Escherichia coli. Ann Microbiol (Paris) (1982) 1.06
Structure of lobster apo-D-glyceraldehyde-3-phosphate dehydrogenase at 3.0 A resolution. J Mol Biol (1980) 1.06
Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells. Structure and expression of the murine prostaglandin EP4 receptor gene. J Biol Chem (1996) 1.06
Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8,-tetrachlorodibenzo-p-dioxin. Arch Biochem Biophys (1996) 1.06
Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol (1997) 1.05
Bimodal distribution of the prostaglandin I2 synthase antigen in smooth muscle cells. J Biol Chem (1983) 1.05
Crystal structure of SQD1, an enzyme involved in the biosynthesis of the plant sulfolipid headgroup donor UDP-sulfoquinovose. Proc Natl Acad Sci U S A (1999) 1.05
Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression. J Exp Med (2000) 1.04
Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 3T3 cells. Arch Biochem Biophys (1993) 1.04
Prostaglandin H synthase: implications for membrane structure. FEBS Lett (1994) 1.04
Biochemical and structural analyses of microtubules in the pellicular membrane of Leishmania tropica. J Protozool (1982) 1.04
Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine (2000) 1.03
Mutational and X-ray crystallographic analysis of the interaction of dihomo-gamma -linolenic acid with prostaglandin endoperoxide H synthases. J Biol Chem (2000) 1.03
The membrane binding domains of prostaglandin endoperoxide H synthases 1 and 2. Peptide mapping and mutational analysis. J Biol Chem (1999) 1.03
Purification of prostacyclin synthase from bovine aorta by immunoaffinity chromatography. Evidence that the enzyme is a hemoprotein. J Biol Chem (1983) 1.01
The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins. Biochim Biophys Acta (1999) 0.99
Orientation of the active site and antigenic determinants of prostaglandin endoperoxide synthase in the endoplasmic reticulum. J Biol Chem (1981) 0.99
Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages. Am J Physiol (1995) 0.97
Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Int (1994) 0.97
Interleukin-1 beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Evidence for their roles in the production of prostaglandin E2. Arthritis Rheum (1994) 0.97
Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences. Arch Biochem Biophys (1992) 0.95
Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J Leukoc Biol (1994) 0.95
Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann N Y Acad Sci (1994) 0.94
Crystallization of the photosystem I reaction centre. EMBO J (1987) 0.93
Rapid induction of prostaglandin endoperoxide synthase in rat preovulatory follicles by luteinizing hormone and cAMP is blocked by inhibitors of transcription and translation. Mol Endocrinol (1989) 0.91
Prostaglandin endoperoxide synthase in rat ovarian follicles: content, cellular distribution, and evidence for hormonal induction preceding ovulation. Endocrinology (1987) 0.91
Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes. Arch Biochem Biophys (1994) 0.91
The formation of stable fatty acid substrate complexes in prostaglandin H(2) synthase-1. Arch Biochem Biophys (2000) 0.90
Concentrations of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta. J Clin Invest (1983) 0.90
Altered arachidonic acid metabolism during differentiation of the human monoblastoid cell line U937. Biochim Biophys Acta (1990) 0.89
Glucocorticoid-induced reduction of prostanoid synthesis in TPA-differentiated U937 cells is mainly due to a reduced cyclooxygenase activity. Biochem Pharmacol (1990) 0.89
Calibration of size-exclusion chromatography: use of a double Gaussian distribution function to describe pore sizes. Anal Biochem (1995) 0.89
Septate junction ultrastructure as visualized in unstained and stained preparations. J Ultrastruct Res (1982) 0.88
Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. Phytomedicine (2002) 0.88
Localization of prostaglandin endoperoxide synthase-1 to the endoplasmic reticulum and nuclear envelope is independent of its C-terminal tetrapeptide-PTEL. Arch Biochem Biophys (1995) 0.87
Lipopolysaccharide induction of monocyte matrix metalloproteinases is regulated by the tyrosine phosphorylation of cytosolic phospholipase A2. J Leukoc Biol (1998) 0.87
Structure-function relationships in sheep, mouse, and human prostaglandin endoperoxide G/H synthases. Adv Prostaglandin Thromboxane Leukot Res (1990) 0.87
Effect of temperature and low pH on structure and stability of matrix porin in micellar detergent solutions. Biochim Biophys Acta (1986) 0.87
The crystallization of outer membrane proteins from Escherichia coli. Studies on lamB and ompA gene products. J Biol Chem (1984) 0.87
Dehydration and embedding temperatures affect the antigenic specificity of tubulin and immunolabeling by the protein A-colloidal gold technique. J Histochem Cytochem (1983) 0.85
Monoclonal antibodies against PGH synthase: an immunoradiometric assay for quantitating the enzyme. Methods Enzymol (1982) 0.85
Expression of the murine prostaglandin (PGH) synthase-1 and PGH synthase-2 isozymes in cos-1 cells. J Lipid Mediat (1993) 0.84
Expression-activity profiles of cells transfected with prostaglandin endoperoxide H synthase measured by quantitative fluorescence microscopy. Biochemistry (1995) 0.83
Cloning of sheep and mouse prostaglandin endoperoxide synthases. Methods Enzymol (1990) 0.83
An examination of the source of the tyrosyl radical in ovine prostaglandin endoperoxide synthase-1. Biochem Biophys Res Commun (1995) 0.82
Peroxidase activity in prostaglandin endoperoxide H synthase-1 occurs with a neutral histidine proximal heme ligand. Biochemistry (2000) 0.81
1-(4-iodobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid, an iodinated indomethacin analog. Acta Crystallogr C (1996) 0.81
A novel, multilayer structure of a helical peptide. Protein Sci (1996) 0.80
X-ray crystal structures of staphylococcal nuclease complexed with the competitive inhibitor cobalt(II) and nucleotide. Biochemistry (1995) 0.80
The aspirin and heme binding sites of PGG/H synthase. Adv Prostaglandin Thromboxane Leukot Res (1991) 0.79
Membrane proteins. Structure, assembly, and function: a panoply of progress. Curr Opin Struct Biol (1997) 0.78
Eicosapentaenoic and docosahexaenoic acids reduce PGH synthase 1 expression in bovine aortic endothelial cells. Biochem Biophys Res Commun (1997) 0.78
Independent prostanoid biosynthetic systems associated with prostaglandin endoperoxide synthases-1 and -2. Thromb Haemost (1997) 0.78
The membrane association sequences of the prostaglandin endoperoxide synthases-1 and -2 isozymes. J Biol Chem (1998) 0.78
Imaging of reconstituted biological channels at molecular resolution by atomic force microscopy. Am J Physiol (1993) 0.78
Studies on coenzyme binding to glyceraldehyde-3-phosphate dehydrogenase. J Mol Biol (1976) 0.77
Membrane protein structural biology minireview series. J Biol Chem (2001) 0.77
X-ray crystallographic study of the structure of prostaglandin H synthase. Adv Exp Med Biol (1997) 0.77